Menu
Call: (647) 352–3233 | Fax: (416) 630–6415
Recent medical advancements in hemorrhoid surgery had resulted in a patient-friendly alternative treatment procedure called the THD Doppler surgery. THD is the short form of Transanal Hemorrhoidal dearterialization. This procedure has proven to be very effective in treating hemorrhoids without modifying the anal anatomy. It involves ligation of the arteries; dearterialization. Ligation of hemorrhoidal arteries and folding the rectal submucosa reduces blood overflow to the affected tissue. The reduced blood flow will help your surgeon to visually find the right position of the displaced prolapsed hemorrhoid tissues. Your surgeon can now put back the tissues into its original site in the anal track without removal of any tissues. THD procedure intervenes in the pathophysiological processes of hemorrhoidal disease. THD surgical method can be used to treat all grades of hemorrhoids.
Usually, the THD procedure is performed on a patient only after a complete analysis of the hemorrhoidal history of the patient. This analysis helps the doctor in determining whether arterial hemorrhoidal ligation is enough or should be followed by the dearterialization of mucopexy for treating the hemorrhoids in the patient. To assess spontaneous bleeding, hemorrhoidal engorgement, and prolapse of pile tissue and rectal mucosa both anorectal examination and anoscopy are performed while the patient rests and strains. THD procedure is normally performed in patients with active hemorrhoidal even after changes in diet/lifestyle, medications and minor procedures like rubber band ligation or sclerotherapy have not proven effective. The patient is administrated with general anesthesia or local anesthesia before the onset of surgery. The patient is also given one or two enemas as the surgery is performed in the anal canal. The surgeon may position the patient in either the lithotomy position or the prone position depending on his preference. The former position allows realistic locating of rectal mucosa and prolapsed hemorrhoids. THD is commonly performed using a specific device produced in Italy. This device consists of a proctoscope mantled with a light source and a Doppler probe. The double crystal in the Doppler probe helps in the better focusing of the ultrasound waves. This in turn helps in easy identification of large-diameter arteries positioned in the upper layers of the rectal wall. Both are crystals are placed apart with sufficient space in between them which allows the adequate vibration of the crystals. The hemorrhoidal artery located using the Doppler probe mounted on oblique support should lie within the operative window so that it can be ligated selectively. First, the anal area is completely lubricated. Then, the lower rectum is reached by inserting a proctoscope through the anal canal. The operation is started by the surgeon at any point about 5 – 6 cm from the anal verge. The Doppler system is turned on. The surgeon rotates or tilts the proctoscope to identify the Doppler signal corresponding to the 6 branches of the hemorrhoidal arteries that are positioned at 1, 3, 5, 7, 9, and 11 o’clock of the anal rectal circumference. Doppler signal also helps in the accurate identification of the arteries positioned at unusual positions. Then the proctoscope is moved back slowly to follow the hemorrhoid artery leading up to its apex to locate the best Doppler signal. The signal is usually clear at the hemorrhoidal site. Anatomical and acoustic findings have confirmed that the prime place to located the hemorrhoidal arteries will be the distal part of the anal rectum. This is the principle of Doppler-guided dearterialization. Once, the best place is located, the Doppler set up is turned off. When the artery is identified in a patient requiring dearterialization alone, the artery is ligated immediately at the point of best Doppler signal with a ‘Z-stitch’. When a patient has to undergo mucopexy as well, the mucosa is marked with a marker point (electro-cautery) at the location of the best Doppler signal. Once the hemorrhoidal artery is marked, the proctoscope is pushed into the rectum, and as a ‘fixation point’ of the mucopexy, a ‘z-stitch’ is sutured. The length of the submucosa and prolapsing mucosa determines the proximal end of the mucopexy. Then, the artery is ligated. The sliding part of the proctoscope is moved back to expose the rectal mucosa. Then, the mucopexy is performed. A continuous suture is used in the mucopexy along the longitudinal axis in a proximal-to-distal direction. The sutures are sutured with an optimal distance of 0.5 cm between them. This helps too tight sutures or too loose sutures. The surgeon makes sure to put two sutures above and below the marker point to trap the hemorrhoidal artery. So, the artery is entrapped within the sutures and the dearterialization is performed using the Doppler-guided dearterialization principle. To ensure blood flow from hemorrhoids, the vertical rows should be spaced from each other. At the apex of the hemorrhoid, the mucopexy running suture is stopped to avoid it being included in the mucopexy. Lastly, the running suture is softly tied. This method is called a hemorrhoid-sparing procedure due to its effectiveness.
This procedure has very little after complications. If the sutures are tight it may lead to tissue ischemia or if too loose causes the early rupture of the suture leading to the collapse of the hemorrhoidal artery. The risk of thrombosis is increased due to the circumferential obliteration of the anal tissue. Urinary retention and Tenesmus are other post-operative complications of the THD procedure. Tenesmus is the condition in which the patient feels the urge to defecate even without the presence of feces. Doctors usually prescribe medications to reduce the pain.
Additional Resources:
Dr. Ravi Kumar completed his Bachelor of Health Sciences at McMaster University. He then pursued his Medical Doctorate and Urology residency at The University of Ottawa. He subsequently completed a fellowship in Urologic Oncology and Robotic Surgery at the Princess Margaret Cancer Centre at the University of Toronto. During his fellowship, he obtained a Master of Engineering from the Institute of Biomedical Engineering at the University of Toronto. He is the co-lead author of the Canadian Urological Association/American Urological Association guideline on the diagnosis and management of adrenal masses.
Dr. Kumar treats a wide variety of urologic conditions including BPH and kidney stones, with a special focus on delivering cutting-edge care for prostate cancer, kidney cancer and bladder cancer.
Dr. Ashwin Maharaj obtained his undergraduate degree in Biology/Physiology from the University of Western Ontario (BSc). e became certified through is a Diplomate of the American Board of Surgery and was certified as fellow of the American College of Surgeons (FACS) and recently recertified. He is a member of the Canadian Association of General Surgeons. His current clinical interests are devoted to outpatient acute and chronic gastrointestinal medicine/surgery as well as abdominal wall hernia surgery and practices in certified facilities in Toronto. He has research experience in gastrointestinal disease as well as surgical education teaching resident surgeons and medical students.
Dr. Diana Magee completed her undergraduate education at Cornell University followed by a Master of Public Health degree at Boston University. She received her medical degree from Queen’s University and completed her urology residency at the University of Toronto. While in residency she enrolled in the Surgeon Scientist program and completed her Master of Science in Health Services Research. She completed her fellowship in urologic oncology at Fox Chase Cancer Center in Philadelphia. Dr. Magee’s area of expertise is in the management of urologic cancers as well as performing minimally invasive surgery.
Dr. Pianezza completed his medical degree (MD) at the University of Ottawa in 2002. He became a member of the Royal College of Physicians of Canada (FRCSC). He then completed a one-year fellowship in minimally invasive surgery and endourology at the University of Alberta in Edmonton in 2008.
Dr. M. Pianezza has been a staff urologist in Sudbury at the Health Sciences North since January 2010. He was Head of Urology from February 2013 to September 2016. He is an Assistant Professor of Surgery at the Northern Ontario School of Medicine.
Dr. Heimrath completed his medical school at the University of Ottawa, his surgical residency at McGill University, and his Endourology, Minimally Invasive, and Robotics Fellowship at the University of Toronto. Dr. Heimrath’s areas of expertise include the management of complex kidney stones and urologic cancers as well as performing minimally invasive surgery. Since 2016, Dr. Heimrath has worked overseas in Malawi and Rwanda to explore opportunities to build urologic and surgical capacity in the developing world. He is a partner in the Urology Global Surgery initiative at the University of Toronto and holds a lecturer appointment with the University of Toronto.
Small intestinal bacterial overgrowth (SIBO) is a clinical condition characterized by a malabsorption syndrome due to an increase in microorganisms within the small intestine.
The Clinic at Beverly Hills offers patients the option between two industry leading gastric balloon procedures. The traditional endoscopy guided Orbera Gastric Balloon and the revolutionary swallowable Allurion Gastric Balloon.
Hemorrhoids are a natural part of the human body and, when healthy, assist with the closure of the anus.
Hemorrhoids are vascular cushions that move blood to and from the anus and help support the function of the sphincter. Most people think of hemorrhoids as the disorder known as hemorrhoids or piles.
Stress Urinary incontinence (SUI) means the uncontrollable loss of urine – an involuntary loss or leakage of urine during precipitating activities like coughing, laughing, sneezing, straining, exercising etc. Early signs of SUI are complaints relating to dysuria, frequency, and urgency. At TCBH Surgical Centre, we offer two treatment options for Stress Urinary Incontinence.
Benign prostatic hyperplasia (BPH) is a condition in which your prostate grows in size. Your prostate is a gland that rests below your bladder and in front of your rectum. It’s about the size of a walnut, and it surrounds part of your urethra. Your urethra is a tube that carries urine and sperm (ejaculate) out of your body. If your prostate grows in size, it can prevent urine and ejaculation from passing through your urethra. BPH is not cancerous. However, symptoms of BPH may indicate more serious conditions, including prostate cancer. TCBH Surgical Centre provides two treatment options.
How The Rezum™ Water Vapor Therapy Works
NanoKnife or Irreversible Electroporation (IRE) consists of placing a number of electrodes into the prostate to surround the area of significant cancer.
Short pulses of electricity using very high voltage are passed between the electrodes. This causes micropores to occur in all cells, including the cancer cells, which lead to their death.
Dr. Luke Fazio is the current Chief of Urology at Humber River Hospital. Dr. Fazio received his medical degree from McGill University in 1999. Following this, he finished his Endourology and Minimally Invasive fellowship at the University of Toronto. As the Urology Medical Director, he has brought many minimally invasive programs to TCBH and is working on future projects. He currently sits on numerous committees and is an advocate for innovation in healthcare. He is the physician lead for the Da Vinci Robotic Surgery Program. He also is the Chair of the Innovation Committee.
Dr. Bhargava has a primary focus of providing care for her patients in the form of minimally invasive procedures and cutting edge technology. She is the Medical Director of TCBH Surgical Centre (The Clinic at Beverly Hills Healthcare) and has been instrumental in bringing Laser Hemorrhoid Treatment to her Centre.
Achievements:
Dr. Bhargava completed both her medical school and surgical residency at the University of Western Ontario. In addition to her Bariatric fellowship, she has also completed Minimally Invasive fellowship at the University of Cincinnati in Ohio.
Dr. Bhargava has published multiple research papers and lead articles.
Memberships:
Canadian Medical Association, Canadian Association of General Surgeons, Society of American Gastrointestinal and Endoscopic Surgeons, Royal College of Physicians and Surgeons of Canada, College of Physicians and Surgeons of Ontario, and American Society of Bariatric Surgery